Leading cause of disability worldwide (WHO)
In most cases, no single structural cause is identified (WHO)
A major global health issue
Chronic low back pain is the leading cause of disability worldwide and a major driver of healthcare and productivity burden (source: WHO). Within this broad population, a relevant group of patients remains stuck despite standard care, cycling through repeated episodes of treatment, temporary relief, and recurrence without regaining durable function. Liveve is built as a repeatable clinic pathway that fits standard operations and scales across sites, with training, protocol guidance, and outcomes tracking to build evidence over time.
A clinic workflow designed for durable function
Liveve combines response guided targeting, a closed loop SSRT reset phase, and immediate retraining, supported by outcomes tracking for repeatable delivery across sites in patients whose recovery has stalled despite usual care.
Response guided targeting
We map segmental neuromuscular response patterns and identify where protective reflex activity appears entrenched. Mapping is guided by measured neural response, not anatomy alone, especially in patients whose symptoms and function are not adequately explained by structural findings.
Closed loop reset protocol
During therapy, SSRT continuously measures the local response and adaptively adjusts pulse parameters to influence segmental reflex circuits, creating a short functional reset window in patients who have become stuck in a protective motor pattern.
Protocol and outcomes tracking
Session data and outcomes support quality, reporting, and consistent delivery across sites, and enable structured learning over time.
Immediate retraining
Within the same pathway, therapists retrain deep motor control and coordination while the system is most responsive, aiming to stabilise a more efficient movement strategy in patients who had previously plateaued in rehabilitation.
Our partners
Selected partners support industrialisation, regulatory readiness, and market entry preparation.
Funding partners
This innovation was funded by the Interreg CrossRoads program Flanders - The Netherlands.
Innovation funding support for development and clinical validation.
Regional funding support for innovation and early commercial readiness.
Strategic partners
Business plan drafting and investor substantiation materials.
Industrialisation and manufacturing support for reliable medical device production at scale.
Choose your path
-
Partner clinics: request a pre market pilot intake
-
Investors: request an investor briefing
-
Scientific reviewers: request the evidence pack